Curated News
By: NewsRamp Editorial Staff
September 10, 2026
SS Innovations' SSi Mantra Hits 14,103 Surgeries, 238 Systems
TLDR
- SS Innovations reports 14,103 SSi Mantra procedures, up 79%, and 238 systems installed, positioning it for FDA and CE mark approvals.
- The SSi Mantra system has enabled 14,103 surgeries across 12 countries through 238 installed systems and 1,500 trained physicians.
- SS Innovations' affordable robotic surgery expands access, improving healthcare globally with 258 pediatric surgeries and 188 telesurgeries.
- SS Innovations' SSi Mantra system facilitated a 13,600-mile telesurgery between Colombia and India, showcasing remote surgical capabilities.
Impact - Why it Matters
This news matters because it demonstrates the accelerating adoption of robotic surgery in emerging markets and beyond, potentially lowering costs and improving access to advanced surgical care. With over 14,000 procedures performed and a rapidly growing installed base, SS Innovations is positioning itself as a key player in the global surgical robotics market. The upcoming FDA and CE mark decisions could open major new markets, increasing competition and driving further innovation. For patients, this means more options for minimally invasive surgery, which can lead to shorter recovery times and better outcomes. For investors, the company's growth trajectory and regulatory milestones could signal significant opportunities in the medtech sector.
Summary
SS Innovations International (NASDAQ: SSII) has announced significant momentum for its SSi Mantra surgical robotic system, reporting 14,103 cumulative procedures as of September 8, 2026—a 79% increase from 7,885 at the end of 2025. The installed base of the system grew 42% to 238 units, up from 168, and the platform is now deployed in 12 countries. Approximately 1,500 physicians have been trained on the SSi Mantra, which has been used for more than 170 types of surgical procedures. Recent international milestones include the launch of robotic cardiac surgery in Colombia, the first SSi Mantra installation in Sri Lanka, and the first telesurgery within the Philippines. The company also highlighted 258 cumulative pediatric robotic surgeries and 188 robotic telesurgeries as of August 31, including a record-breaking telesurgery spanning more than 13,600 miles between Colombia and India. In August, five SSi Mantra systems were used to complete 50 robotic general surgery procedures in a single day in India.
Looking ahead, SS Innovations expects the U.S. Food and Drug Administration to complete its review of the SSi Mantra 510(k) premarket notification by the end of the first quarter of 2027 and believes European Union CE marking certification can be obtained by year-end 2026. The company’s product range includes the SSi Mantra system and the SSi Mudra suite of surgical instruments, which support a variety of procedures including cardiac surgery. An American company headquartered in India, SS Innovations aims to make robotic surgery affordable and accessible to a larger segment of the global population. For more details, visit https://ibn.fm/DJILj. The latest updates on SSII are available in the company’s newsroom at https://ibn.fm/SSII. InvestorWire, a specialized communications platform, powered by IBN, distributed this announcement.
Source Statement
This curated news summary relied on content distributed by InvestorBrandNetwork (IBN). Read the original source here, SS Innovations' SSi Mantra Hits 14,103 Surgeries, 238 Systems
